Neolpharma II
Sector: Water Supply and Storage • Location: Mexico
Source: International Finance Corporation (IFC)
Grupo Neolpharma (“Neolpharma” or “the Group”) is a family-owned pharmaceutical company primarily operating in Mexico. It offers over 250 branded and generic medicines across various therapeutic areas, including central nervous system (CNS) diseases, cardiovascular diseases, oncology, and diabetes. In 2021, IFC financed Neolpharma’s initial expansion plan, encompassing the construction of a new i
- Status
- Prospective
- Sector
- Water Supply and Storage, Hospital, Manufacturing (Industrial), Government
- Location
- Mexico
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Neolpharma II
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | pending |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Grupo Neolpharma (“Neolpharma” or “the Group”) is a family-owned pharmaceutical company primarily operating in Mexico. It offers over 250 branded and generic medicines across various therapeutic areas, including central nervous system (CNS) diseases, cardiovascular diseases, oncology, and diabetes. In 2021, IFC financed Neolpharma’s initial expansion plan, encompassing the construction of a new injectables facility in Mexico City, the expansion of an active pharmaceutical ingredients (APIs) production plant in Ecatepec, Mexico, and other related expenditures (#39128). IFC is now proposing a new $70 million long-term corporate loan to support Neolpharma’s further expansion plan in Mexico (“the Project”). The Project includes (i) the acquisition, refurbishment, and reactivation of the NeolSym Civac API plant in Morelos (“API Plant”); (ii) the construction of a new injectables facility in Toluca to provide drug manufacturing services for a third party (“CMO Plant”); and (iii) technological upgrades and new equipment for Neolpharma’s existing plants, including the refurbishing of corporate offices. |
Original sector | G-FA - Pharmaceuticals and Medicine Manufacturing |
Budget |
Location
Country | Mexico |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Water Supply and Storage, Hospital, Manufacturing (Industrial), Government |
Article published date | 2026-03-05 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project